Patents by Inventor Kenneth David

Kenneth David has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8765743
    Abstract: The invention is directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: July 1, 2014
    Assignee: Glaxosmithkline Intellectual Property Development Limited
    Inventors: Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin, Joelle Le, Christopher James Lunniss, Nigel James Parr, Timothy John Ritchie, Juliet Kay Simpson, Christian Alan Paul Smethurst
  • Publication number: 20140181305
    Abstract: Scheduling a scheduled and optionally periodic action in a remote based system. The method includes deploying an environment independent action to a remote based system. The action is limited to using a predetermined amount of resources and is limited to simple, non-cpu intensive orchestrations of network calls. The method further includes defining a schedule for the action to be executed. Calling the action at the remote based system based on the schedule in a processor independent fashion such that state of the action is maintained independent of the processor that the action is being executed on.
    Type: Application
    Filed: December 26, 2012
    Publication date: June 26, 2014
    Applicant: MICROSOFT CORPORATION
    Inventors: Kenneth David Wolf, Clark Roberts, Leon Ezequiel Welicki, Andrei Romanenko, Christopher Lloyd Gillum, Kevin Lam
  • Publication number: 20140181826
    Abstract: Scheduling and dispatching jobs for a plurality of different entities. A method includes receiving at a work coordinator, one or more actions associated with a job. The method further includes storing in a log at the work coordinator, keyed on a job key, state for the one or more actions and a list of the one or more actions. The method further includes making calls to one or more worker processes to cause the worker process to perform actions associated with the job. As a result of making calls to one or more worker processes, the method further includes receiving at least one of a change to the list of remaining actions or the state.
    Type: Application
    Filed: December 26, 2012
    Publication date: June 26, 2014
    Applicant: MICROSOFT CORPORATION
    Inventors: Kenneth David Wolf, Jesus Ruiz-Scougall, Nathan Christopher Talbert, Clark Roberts
  • Patent number: 8731897
    Abstract: A data protection and storage system includes an array of disk drives for data storage. Data is received for storage on the disk drive via an interface that is configured to emulate a tape drive interface. A virtual tape data structure is created and stored on the disk drives. The allocated capacity of the virtual tape is dynamically and transparently alterable in response to data storage demand within the virtual tape.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: May 20, 2014
    Assignee: Overland Storage, Inc.
    Inventors: John E. Matze, Michael H. Reider, Kenneth David Geist, Daniel Morgan Davies
  • Publication number: 20140135387
    Abstract: Equol (7-hydroxy-3(4?hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5?-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes.
    Type: Application
    Filed: May 28, 2013
    Publication date: May 15, 2014
    Applicants: Brigham Young University, Children's Hospital Center, Colorado State University Research Foundation
    Inventors: Edwin Douglas Lephart, Trent D. Lund, Kenneth David Reginald Setchell, Robert J. Handa
  • Publication number: 20140125178
    Abstract: A magnetic electrical generator includes a rotational device that rotates a flywheel. The flywheel includes a plurality of magnetic elements that are arranged to alternate in polarity. The plurality of magnets is rotated in between a top and a bottom of at least one pole piece, which creates an alternating B field that is coupled to a pickup coil.
    Type: Application
    Filed: November 5, 2012
    Publication date: May 8, 2014
    Inventor: Kenneth David Chase
  • Patent number: 8716497
    Abstract: A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the enantioselective preparation of enantiomeric equol. A preferred Ir catalyst has a chiral phosphineoxazoline ligand. Enantiomeric chromanes of high stereoselective purity can be obtained.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: May 6, 2014
    Assignees: Children's Hospital Medical Center, Ausio Pharmaceuticals, Inc.
    Inventors: Kenneth David Reginald Setchell, Victor Dmitrievich Sorokin
  • Publication number: 20140114997
    Abstract: An apparatus, system, and method are disclosed for generating contact plans and responding to web form inquires using the contact plans.
    Type: Application
    Filed: July 3, 2013
    Publication date: April 24, 2014
    Applicant: InsideSales.com, Inc.
    Inventors: Thomas Jeffrey Purdy, David Randal Elkington, Jeremiah Johnson, Kenneth David Krogue, James B. Oldroyd
  • Patent number: 8668914
    Abstract: Equol (7-hydroxy-3(4?hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5?-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies of skin and hair. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes affecting skin and hair.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: March 11, 2014
    Assignees: Brigham Young University, Colorado State University Research Foundation, Children's Hospital Medical Center
    Inventors: Edwin Douglas Lephart, Trent D. Lund, Kenneth David Reginald Setchell, Robert J. Handa
  • Patent number: 8665482
    Abstract: A raster image processor (RIP) using a self-tuning banding mode is disclosed. The RIP automatically and continuously adjusts the band size used for generating the raster image based on past performance (i.e. past data throughput values) and corresponding band sizes. At the start of each page of image, or after a certain number of pages has been processed or certain amount of time has elapsed, the RIP determines whether performance has worsened since the last band size adjustment. If it has worsened, the band size is reverted to a previous best performing value. If the performance has improved, then the band size is changed in the same direction as the last change. Raster image processing is performed using the adjusted band size.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: March 4, 2014
    Assignee: Konica Minolta Laboratory U.S.A., Inc.
    Inventors: Darrell Vaughn Hopp, Kenneth David Hayber
  • Patent number: 8658635
    Abstract: The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: February 25, 2014
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin, Joelle Le, Christopher James Lunniss, Nigel James Parr, Timothy John Ritchie, John Edward Robinson, Juliet Kay Simpson, Christian Alan Paul Smethurst
  • Publication number: 20140039046
    Abstract: A composition for use in making commercial food and skin products comprising 5-equol or mixtures, including both a non-racemic mixture and a racemic mixture, of S-equol and R-equol. The composition can be used to make articles of commerce such as food supplements, pharmaceuticals, and medicaments. The compositions are useful in a method of delivering S-equol to a mammal to prevent or treat a disease or associated condition, including hormone-dependent diseases or conditions such as cardiovascular disease, lipid disorder, osteopenia, osteoporosis, liver disease, and acute ovarian estrogen deficiency. The S-equol enantiomer can be produced in a biological synthesis from the metabolism of an isoflavone by an organism.
    Type: Application
    Filed: August 28, 2013
    Publication date: February 6, 2014
    Applicants: CHILDREN'S HOSPITAL MEDICAL CENTER, AUSTRALIAN HEALTH & NUTRITION ASSOCIATION LIMITED
    Inventors: Kenneth David Reginald SETCHELL, Sidney John COLE
  • Publication number: 20140040943
    Abstract: A multiple Interactive Program Guide (IPG) system provides different television programming and different IPGs to several different users respectively. A single set-top box is capable of providing programming and scheduling data to several different television sets. Each of the different IPGs share a common database. Therefore, a first IPG being viewed by a first user can display data added or modified via a second IPG by a second user of the system. Furthermore, the data added or modified by the second user can influence the viewing rights of the first user. Also, all the competing and conflicting requests for limited resources, such as VCR scheduled recordings, will be brought to the users' attention and will be displayed by the system.
    Type: Application
    Filed: October 4, 2013
    Publication date: February 6, 2014
    Applicant: Starsight Telecast, Inc.
    Inventors: James H. Knowles, Kenneth David Johnson, Gordon Chang
  • Patent number: 8626888
    Abstract: A method, system, and article for autonomizing autonomic management of a data center, with the data center having at least one computer system and an associated component. Data is collected from the data center and used as input to identify a data center policy. A set of capabilities of elements of the data center are detected and cataloged based upon the collected data. At least one policy is dynamically selected from at least one set of master policies in a policy directory with the selected policy to support the cataloged capabilities of the data center, and to dynamically control selective application and to adapt parameters for quality of service. The selected policy is applied to manage the data center.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: January 7, 2014
    Assignee: International Business Machines Corporation
    Inventors: Naga A. Ayachitula, Vijaya Jas, Kenneth David Christiance, Peter M. Jensen, Josephine E. Justin, Robert Larsen, Ann M. Moyer, Lisa Nayak, Rajeev Puri, Cheranellore Vasudevan, Chetna Dnyandeo Warade
  • Patent number: 8620991
    Abstract: Technologies for enabling a continuation based runtime to accept or reject external stimulus and, in addition, to determine if an external stimulus may be valid for processing at a later point in execution.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: December 31, 2013
    Assignee: Microsoft Corporation
    Inventors: Kenneth David Wolf, Justin David Brown, Karthik Raman, Nathan Christopher Talbert, Edmund Samuel Victor Pinto
  • Patent number: 8615817
    Abstract: The present invention provides protective headgear comprising a shell (26) having an inwardly facing surface which in use faces the head (10) of a user of the headgear and an outwardly facing surface which in use faces away from the head (10) of a user. An outer layer (28) overlies at least a portion of the outwardly facing surface of the shell (26) and rupturing means (30) is provided for fixedly attaching the outer layer (28) to the remainder of the headgear at one or more locations. The rupturing means (30) is configured so as to fail when a force greater than a selected threshold is received on an outer surface (28) of the headgear which acts in an at least part tangential direction to rotate the headgear and the head (10) of the user.
    Type: Grant
    Filed: July 9, 2002
    Date of Patent: December 31, 2013
    Assignee: Phillips Helmets Limited
    Inventor: Kenneth David Phillips
  • Patent number: 8613308
    Abstract: One exemplary embodiment can be a process for transferring heat to a first stream from a second stream in a hydrocarbon process. The process can include passing the first stream through at least one generally vertically-orientated tube in an exchanger. An interior surface of the at least one generally vertically-orientated tube may form one or more curved irregularities where the first stream, prior to entering the at least one generally vertically-orientated tube, may include a mixture of a gas including hydrogen and at least one or more C1-C3 hydrocarbons, and a liquid including one or more C4-C13 hydrocarbons.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: December 24, 2013
    Assignee: UOP LLC
    Inventors: Phillip F. Daly, Kenneth David Peters
  • Publication number: 20130336865
    Abstract: A NOx absorber catalyst comprising a substrate monolith coated with one or more washcoat layers and comprising a first component comprising a nitrogen oxide storage component, at least one precious metal and a dispersed rare earth oxide supported on a refractory support material, and a second component comprising a precious metal supported on a bulk reducible oxide that is substantially free of nitrogen oxide storage material, wherein the precious metal present in the second component comprises Pt, Pd or a combination of both Pt and Pd and wherein the bulk reducible oxide is an oxide, a composite oxide or a mixed oxide comprising at least one of manganese, iron, cobalt, copper, tin or cerium.
    Type: Application
    Filed: December 21, 2011
    Publication date: December 19, 2013
    Applicant: JOHNSON MATTHEY PUBLIC LIMITED COMPANY
    Inventors: Robert James Brisley, Kenneth David Camm, Noelia Cortes Felix, Fiona-Mairead McKenna, Paul James Millington, Elizabeth Hazel Mountstevens, Daniel Swallow
  • Publication number: 20130331537
    Abstract: Polymeric materials referred to herein as PEU include a plurality of linking groups selected from urea and urethane groups, and a plurality of segments located between adjacent linking groups, where at least some of the segments of the PEU are polyoxyalkylene, but other exemplary segments include hydrocarbons, polyesters, polycarbonates and polysiloxanes. The polymeric materials are biocompatible and may be used, for example, to replace or supplement cartilage in an articulated joint.
    Type: Application
    Filed: June 7, 2013
    Publication date: December 12, 2013
    Inventors: Kenneth David Gray, JR., Joel Thomas Corbett, Georgios Theofanis Hilas
  • Patent number: 8580846
    Abstract: The invention is directed to a method of preventing or ameliorating a neuropsychiatric or neurodegenerative disease or disorder in a subject. The method includes administering a composition comprising equol in an amount sufficient to prevent or ameliorate the neuropsychiatric or neurodegenerative disease or disorder. The equol may be a racemic mixture of R-equol and S-equol. The equol may be enantiomerically enriched with R-equol or enantiomerically enriched with S-equol.
    Type: Grant
    Filed: August 18, 2006
    Date of Patent: November 12, 2013
    Assignees: Brigham Young University, Children's Hospital Medical Center, Colorado State University Research Foundation
    Inventors: Edwin Douglas Lephart, Trent D. Lund, Kenneth David Reginald Setchell, Robert J. Handa